{"denoms":[{"counts":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"5"}],"units":"Participants"}],"groups":[{"description":"Encorafenib 450mg QD Binimetinib 45mg BID 28 day cycle\n\nResearch Bloods\n\nEncorafenib: 450mg QD 28 day cycle\n\nBinimetinib: 45mg BID 28 day cycle\n\nResearch Bloods: Baseline; pre-cycle 3; Pre-cycle 7; off Treatment\n\nTumor Tissue: at time of surgery contrast enhancing and non enhancing tumor; 20 unstained slides","id":"BG000","title":"Treatment Cohort 1 AA & GBM"},{"description":"Encorafenib 450mg QD Binimetinib 45mg BID 28 day cycle\n\nResearch Bloods\n\nEncorafenib: 450mg QD 28 day cycle\n\nBinimetinib: 45mg BID 28 day cycle\n\nResearch Bloods: Baseline; pre-cycle 3; Pre-cycle 7; off Treatment\n\nTumor Tissue: at time of surgery contrast enhancing and non enhancing tumor; 20 unstained slides","id":"BG001","title":"Treatment Cohort 2 Anaplastic PXAs"},{"description":"Pre-op -14 days: Encorafenib 450mg QD and Binimetinib 45mg BID last dose of both drugs 2hrs prior to surgery\n\nTumor; research blood; CSF samples\n\npost surgery: Encorafenib 450mg QD Binimetinib 45mg BID 28 day cycle\n\nEncorafenib: 450mg QD 28 day cycle\n\nBinimetinib: 45mg BID 28 day cycle\n\nResearch Bloods: Baseline; pre-cycle 3; Pre-cycle 7; off Treatment\n\nTumor Tissue: at time of surgery contrast enhancing and non enhancing tumor; 20 unstained slides","id":"BG002","title":"Surgical Arm"},{"description":"Encorafenib 450mg QD Binimetinib 45mg BID 28 day cycle\n\nResearch Bloods\n\nEncorafenib: 450mg QD 28 day cycle\n\nBinimetinib: 45mg BID 28 day cycle\n\nResearch Bloods: Baseline; pre-cycle 3; Pre-cycle 7; off Treatment\n\nTumor Tissue: at time of surgery contrast enhancing and non enhancing tumor; 20 unstained slides","id":"BG003","title":"Treatment Cohort 3 Other Tumors"},{"description":"Total of all reporting groups","id":"BG004","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"22","upperLimit":"39","value":"30"},{"groupId":"BG001","lowerLimit":"27","upperLimit":"77","value":"75"},{"groupId":"BG003","lowerLimit":"26","upperLimit":"26","value":"26"},{"groupId":"BG004","lowerLimit":"22","upperLimit":"77","value":"38"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"3"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"2"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"5"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"4"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"4"}],"title":"100-80"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}],"title":"70-60"}]}],"description":"Higher score better \"100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs\"","paramType":"COUNT_OF_PARTICIPANTS","title":"Karnofsky Performance Status Scale","unitOfMeasure":"Participants"}],"populationDescription":"No patient were enrolled on the Surgical arm. this study was terminated early by a mandate from NCI to shut down the ABTC Consortium due to wanting a different strategy for Brain Tumor Research. As such,"}